The Measles & Rubella Initiative is a global entity that provides funding and technical support directly to countries to address measles and rubella outbreaks. Through annual funding from Gavi, the Vaccine Alliance, and other supporters the M&RI partners are able to rapidly provide resources to countries experiencing outbreaks for targeted response activities including the purchase of vaccines and operational costs. M&RI has provided technical support to numerous countries working to prevent and stop measles outbreaks. This support is pivotal and sets M&RI and its five founding partners apart, making it all the more unique. In addition to technical support, M&RI Outbreak Response Funds have been provided to five countries (table.)
Countries Receiving M&RI Outbreak Response Funds in 2019
|Country||Target Population||Date Approved|
|Ethiopia||301,097||April 11th, 2019|
|Lao PDR||224,281||April 11th, 2019|
|DRC||2,488,142||January 31st, 2019|
|Cambodia||108,539||April 4th, 2019|
|Nigeria||838,582||April 5th, 2019 & May 14th, 2019|
Read the latest news about ongoing immunization campaigns throughout the world.
- The Minister of Health in the Democratic Republic of Congo Declares a Measles Epidemic
- Over 100,000 people sick with measles in 14 months
- M&RI, Gavi, partners help vaccinate 7.2 million children in Madagascar against measles
- Over 109,000 people died from measles in 2017 — needlessly
A dynamic visual aide showing current progress and challenges in the Measles & Rubella Initiative’s campaigns.